Pricing Log in Create free account

Caris Life Sciences,�Inc. (CAI) vs Corcept Therapeutics Incorporated (CORT)

Caris Life Sciences,�Inc. and Corcept Therapeutics Incorporated are both Biotechnology companies. Caris Life Sciences,�Inc. and Corcept Therapeutics Incorporated are of similar size ($7.8B and $7.4B). Corcept Therapeutics Incorporated trades at the lower P/E: 47.8× against 73.9×. Caris Life Sciences,�Inc. grew revenue faster over the last twelve months: 68.8% against 30.0%. Corcept Therapeutics Incorporated has the higher net margin (16.5% vs 9.16%) and the lower return on invested capital (15.0% vs 33.0%). Across the 20 metrics below, Corcept Therapeutics Incorporated leads on 12 and Caris Life Sciences,�Inc. on 8.

Valuation

Metric CAI CORT Biotechnology median
P/E 73.94 47.81 10.60
P/S 6.80 8.04 9.40
P/B 11.15 9.29 2.13
Price to free cash flow 246.58 39.79 25.18
EV/EBITDA 40.62 67.93 0.66
EV/Sales 6.44 7.67 9.02
Earnings yield 1.35% 2.09% (32.88%)
Free cash flow yield 0.41% 2.51% (23.13%)

Profitability

Metric CAI CORT Biotechnology median
Gross margin 69.09% 98.54% 68.51%
Operating margin 13.35% 11.51% 0.00%
Net margin 9.16% 16.54% 0.00%
Free cash flow margin 2.76% 20.20% 0.00%
Return on equity 17.19% 21.74% (51.96%)
Return on assets 8.58% 17.16% (46.06%)
Return on invested capital 32.96% 14.97% 0.00%

Growth

Metric CAI CORT Biotechnology median
Revenue growth (TTM) 68.84% 30.02% 6.76%
EPS growth (last fiscal year) 69.79% (33.33%) 29.88%
Revenue growth, 5-year CAGR — 16.56% 9.75%
Net income growth, 5-year CAGR — (1.52%) 0.00%

Health

Metric CAI CORT Biotechnology median
Debt to equity 0.62 0.00 0.00
Current ratio 6.71 3.00 4.97
Net debt to EBITDA (5.23) (8.83) 1.01

Dividend

Metric CAI CORT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CAI CORT Biotechnology median
Market cap 7.36b 7.84b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack